InvestorsHub Logo
Followers 70
Posts 3219
Boards Moderated 0
Alias Born 07/11/2011

Re: None

Monday, 09/21/2015 6:36:26 PM

Monday, September 21, 2015 6:36:26 PM

Post# of 32016
Aloha Crew: Let's review. Shall we?
Worlds only and first inhaled Monomeric insulin
No need for complex titration or carbohydrate counting except type 1,s.
No weight gain or weight neutral
Superior glycemic controls
Peaks in 10 minutes and out of the body in 3 hours mimicking the healthy individuals genetic profile
Less then 30 seconds difference from the healthy pancreas release.
No shot
No site scaring
KOL's say it's obvious that Afrezza halts progression
Study of T2 where they had Afrezza alone, ate nothing, and had zero hypos in all cases..
FDA approved
Partnered with Sanofi
Sanofi partnered with Google
Google partnered with Dexcom
Dexcom CEO says..Afrezza users in heaven
And the stock has 130,000,000 million shorts at $3.36 a share..
Is that about right?
Oh..and Sanofi doing clinical in 4 year to 18 year olds..pending UK approval..and results of a clamp study

Our time is coming Crew. Just hang in there.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y